Phase I/II trial of biweekly paclitaxel and cisplatin in the treatment of metastatic breast cancer.

Gelmon, K A; O'Reilly, S E; Tolcher, A W; Campbell, C; Bryce, C; Ragaz, J; Coppin, C; Plenderleith, I H; Ayers, D; McDermott, B; Nakashima, L; Healey, D; Onetto, N

Gelmon, K A; O'Reilly, S E; Tolcher, A W; Campbell, C; Bryce, C; Ragaz, J; Coppin, C; Plenderleith, I H; Ayers, D; McDermott, B; Nakashima, L; Healey, D; Onetto, N.

Affiliation

Gelmon KA; British Columbia Cancer Agency, Vancouver, Canada.

J Clin Oncol ; 14(4): 1185-91, 1996 Apr.

Article in En | MEDLINE | ID: mdl-8648373

Subject(s)

Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Breast Neoplasms/drug therapy; Adult; Aged; Antineoplastic Agents, Phytogenic/administration & dosage; Antineoplastic Combined Chemotherapy Protocols/adverse effects; Breast Neoplasms/pathology; Cisplatin/administration & dosage; Drug Administration Schedule; Feasibility Studies; Female; Humans; Middle Aged; Paclitaxel/administration & dosage; Treatment Outcome

Search on Google

XML

PubMed Links

Database: MEDLINE Main subject: Breast Neoplasms / Antineoplastic Combined Chemotherapy Protocols Limits: Adult / Aged / Female / Humans / Middle aged Language: En Year: 1996 Type: Article

Search on Google

XML

PubMed Links